當台股加權指數下修幅度超過一成六，台灣生技產業市值卻逆勢增加7%左右，甚至在今年6月底市值創下歷史新高，其中新藥研發、藥品製造成為關鍵力量。 藥華藥、合一 兩屆生技股王如何開創巔峰？疫情後下一波生技的機會又在哪裡？《今周刊》生技100大報告將為你全盤解析。 主持人 | 今周刊總編輯楊紹華 與談人 | 今周刊記者譚偉晟 期數主題 | 1333期 新藥股憑什麼夯？ -- **25周年慶訂閱優惠 | 訂《今周刊》紙本一年52期再送25期 https://bit.ly/3wfCXGe (粉絲專屬優惠折扣碼：78YMm) **當期雜誌 *https://reurl.cc/j1AGA1 **意見信箱 *[email protected] -- Hosting provided by SoundOn
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Trump $82 Million Bond Spree, Brazil Tariffs 'Too High,' More
16 Nov 2025
Bloomberg News Now
Ex-Fed Gov Resigned After Rules Violations, Trump Buys $82 Mil of Bonds, More
16 Nov 2025
Bloomberg News Now
THIS TRUMP INTERVIEW WAS INSANE!
16 Nov 2025
HasanAbi
Epstein Emails and Trump's Alleged Involvement
15 Nov 2025
Conspiracy Theories Exploring The Unseen
New Epstein Emails Directly Implicate Trump - H3 Show #211
15 Nov 2025
H3 Podcast
Trump Humiliates Himself on FOX as They Call Him Out
15 Nov 2025
IHIP News